ArticleOpen forum infectious diseases2023

Effectiveness of Booster Doses of Monovalent mRNA COVID-19 Vaccine Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children, Adolescents, and Adults During Omicron Subvariant BA.2/BA.2.12.1 and BA.4/BA.5 Predominant Periods.

Allison Avrich Ciesla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.